|
|
|
|
When Choosing Antibiotic Regimen, Location Is Key
Miami Beach, Fla.-A three-drug regimen consisting of double gram-negative coverage plus methicillin-resistant Staphylococcus aureus (MRSA) coverage is a must for increasing the success of proper initial empiric antibiotic selection, according to a study...
|
|
|
Penile implant infection control strategies vary widely
San DiegoThere is a great deal of variation in infection control strategies among surgeons who implant penile prostheses, prompting the need for detailed guidelines that may be difficult to formulate, two groups reported at the Sexual Medicine Society of North...
|
|
|
Ceftaroline Will Earn Peak Year Sales of up to $200 Million in the Community-Acquired Pneumonia Drug Market
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, following its expected launch later this year in the United States and in 2011 in Europe and Japan, Forest Laboratories/AstraZeneca...
|
|
|
Ceftaroline Will Earn Peak Year Sales of up to $200 Million in the Community-Acquired Pneumonia Drug Market
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, following its expected launch later this year in the United States and in 2011 in Europe and Japan, Forest Laboratories/AstraZeneca...
|
|
|
Ceftaroline Will Earn Peak Year Sales of up to $200 Million in the Community-Acquired Pneumonia Drug Market
Between 2010 and 2015, Ceftaroline is Poised to be the Only Marketed Anti-MRSA Cephalosporin for the Indication, According to New Findings from Decision Resources WALTHAM, Mass., March 2 /PRNewswire/ -- Decision Resources, one of the world's leading research...
|
|
|
Ceftaroline Will Earn Peak Year Sales of up to $200 Million in the Community-Acquired Pneumonia Drug Market
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, following its expected launch later this year in the United States and in 2011 in Europe and Japan, Forest Laboratories/AstraZeneca...
|
|
|
Ceftaroline Will Earn Peak Year Sales of up to $200 Million in the Community-Acquired Pneumonia Drug Market
WALTHAM, Mass., March 2 -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, following its expected launch later this year in the United States and in 2011 in Europe and Japan,...
|
|
|
Publishing holiday for President's Day
Free newsletter via e-mail Tools Despite a blizzard that paralyzed much of the East Coast (and kept Fierce's DC- and Philadelphia-based editors snowed in), it was a busy week for FierceBiotech.John Carroll (twitter) made it to New York for the Annual BIO CEO...
|
|
|
Wockhardt gets US FDA's tentative approval to market Levofloxacin tabs
Pharmaceutical and biotechnology major Wockhardt has received tentative approval from the United States Food & Drug Administration (US FDA) for marketing the 250mg, 500mg and 750mg tablets of Levofloxacin, which is used for treatment in a broad spectrum of...
|
